Get the Stockscreener App
0.1679
0.71%
-0.0012
Pre-market:
.17
0.0021
+1.25%
VolitionRX Ltd stock is traded at $0.1679, with a volume of 3.27M.
It is down -0.71% in the last 24 hours and down -15.24% over the past month.
VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.1691
Open:
$0.17
24h Volume:
3.27M
Relative Volume:
0.31
Market Cap:
$22.76M
Revenue:
$1.73M
Net Income/Loss:
$-23.50M
P/E Ratio:
-0.7688
EPS:
-0.2184
Net Cash Flow:
$-19.37M
1W Performance:
-16.88%
1M Performance:
-15.24%
6M Performance:
-74.17%
1Y Performance:
-66.41%
1-Day Range:
$0.1502
$0.1706
1-Week Range:
$0.1502
$0.20
52-Week Range:
$0.1502
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
Name
VolitionRX Ltd
Sector
Industry
Phone
646 650 1351
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Compare VNRX vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.1679 | 22.76M | 1.73M | -23.50M | -19.37M | -0.2184 |
TMO
Thermo Fisher Scientific Inc
|
489.50 | 181.84B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.01 | 135.18B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
574.80 | 45.65B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
113.88 | 32.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
307.38 | 30.15B | 3.17B | 642.63M | 516.49M | 10.77 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-08-25 | Initiated | H.C. Wainwright | Buy |
| Feb-01-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Feb-17-22 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-10-21 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-18 | Initiated | Maxim Group | Buy |
| May-14-18 | Reiterated | The Benchmark Company | Buy |
| Sep-07-16 | Reiterated | Rodman & Renshaw | Buy |
| Feb-01-16 | Initiated | Rodman & Renshaw | Buy |
View All
VolitionRX Ltd Stock (VNRX) Latest News
H.C. Wainwright cuts VolitionRX stock price target to $1 on share count - Investing.com Australia
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain - TipRanks
VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK
VolitionRX (VNRX) FY2025 Earnings: Q4 EPS and Revenue Not Disclo - GuruFocus
VolitionRX Is Maintained at Buy by HC Wainwright & Co. - Moomoo
VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript - insidermonkey.com
VolitionRX Q4 Earnings Call Highlights - defenseworld.net
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong R - GuruFocus
VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut - TipRanks
VolitionRX (VNRX) Sees Target Price Cut Despite Maintained Buy R - GuruFocus
VolitionRx Limited (VNRX) 8-K SEC Filing March 31, 2026: Company Details, Address, and Stock Information - Minichart
VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results By Investing.com - Investing.com South Africa
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results - Investing.com
Q4 2025 VolitionRX Ltd Earnings Call Transcript - GuruFocus
VolitionRx : Corporate Presentation April 2026 - marketscreener.com
VNRX|VolitionRX Ltd|Price:0.200|Chg%:-0.00 - TradingKey
VolitionRX's Nu.Q Cancer Reimbursement Decision in Q4 2026 Could Unlock Commercial Licensing Momentum Amid Dilution Risks - Bitget
VolitionRx secures €2M in Belgian government financing By Investing.com - Investing.com South Africa
Volitionrx Ltd earnings beat, revenue fell short of estimates By Investing.com - Investing.com India
Volitionrx Ltd earnings beat, revenue fell short of estimates - Investing.com UK
VolitionRX Q4 2025 Earnings Call Transcript - MarketBeat
VolitionRX: Q4 Earnings Snapshot - theheraldreview.com
VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital | - GuruFocus
VolitionRx (NYSE: VNRX) details going concern risk, funding needs and Nu.Q® rollout - Stock Titan
Volition says its tests are nearing hospital use in lung cancer and sepsis - Stock Titan
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital - Moomoo
VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Belgian agencies give VolitionRx €2M to advance tests for poorer countries - Stock Titan
VolitionRx biomarkers show elevation in trauma patients study By Investing.com - Investing.com South Africa
VolitionRx biomarkers show elevation in trauma patients study - investing.com
A blood test before lung surgery helped flag higher-risk patients - stocktitan.net
VolitionRx to outline 2025 results and milestones on April 1 - Stock Titan
VolitionRx Limited (VNRX) Stock: Rallies on Promising Multi-Cancer Early Detection Breakthrough - parameter.io
Blood test detects 95% of stage I and II cancers in blinded study - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
VNRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VolitionRx (NYSE: VNRX) CCO shares withheld and cancelled for RSU taxes - Stock Titan
Tax withholding reduces VolitionRx (NYSE: VNRX) secretary’s share count - Stock Titan
VolitionRx (VNRX) CSO uses 5,310 shares to cover tax bill - Stock Titan
VolitionRx (VNRX) GC has 7,003 shares cancelled for tax withholding - Stock Titan
In today's session, these stocks are experiencing unusual volume. - ChartMill
VNRX Receives Unchanged 'Buy' Rating from D. Boral Capital | VNR - GuruFocus
VolitionRX Ltd (VNRX) Stock Price, Quote, News & History - Benzinga
VolitionRx Limited (VNRX) Stock: Jumps on World-First Cancer DNA Isolation Breakthrough - parameter.io
These stocks are the most active in today's session - ChartMill
Stock Market Volume Leaders: Nasdaq, NYSE, and NYSE American Trading ActivityNews and Statistics - IndexBox
Aug Drivers: What is the cash position of VolitionRx Limited2026 Biggest Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery - Blockonomi
VolitionRX Ltd Stock (VNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):